Supplement Claims Rules v. Drugs, Foods: FDA Opens Free Speech Debate
This article was originally published in The Tan Sheet
Executive Summary
FDA invites public comments on the constitutionality of its approach to regulating claims for dietary supplements compared with Rx drugs and foods in a notice appearing in the May 16 Federal Register
You may also be interested in...
Structure/Function Claim Pre-Market Substantiation Urged By Former FDAer
A mandatory pre-market substantiation program for structure/function claims covering both foods and dietary supplements should be created by FDA, former deputy commissioner for policy Michael Taylor contends
Structure/Function Claim Pre-Market Substantiation Urged By Former FDAer
A mandatory pre-market substantiation program for structure/function claims covering both foods and dietary supplements should be created by FDA, former deputy commissioner for policy Michael Taylor contends
Structure/Function Claim Pre-Market Substantiation Urged By Former FDAer
A mandatory pre-market substantiation program for structure/function claims covering both foods and dietary supplements should be created by FDA, former deputy commissioner for policy Michael Taylor contends